title: Treatment of Multifocal Renal Cell Carcinoma in a Solitary Kidney With Nivolumab.
authors.affiliation: Kidney Cancer Program, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
authors.forename: Brian
authors.initials: B
authors.lastname: Shinder
authors.affiliation: Kidney Cancer Program, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Farber
authors.affiliation: Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
authors.forename: Tina
authors.initials: T
authors.lastname: Mayer
authors.affiliation: Kidney Cancer Program, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ. Electronic address: eric.singer@rutgers.edu.
authors.forename: Eric A
authors.initials: EA
authors.lastname: Singer
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D000077594:Nivolumab; D000075529:Solitary Kidney / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000077594:Nivolumab
keywords: Immunotherapy; Partial nephrectomy; Targeted therapy